1. Home
  2. CCIR vs ABSI Comparison

CCIR vs ABSI Comparison

Compare CCIR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCIR
  • ABSI
  • Stock Information
  • Founded
  • CCIR 2021
  • ABSI 2011
  • Country
  • CCIR United States
  • ABSI United States
  • Employees
  • CCIR N/A
  • ABSI N/A
  • Industry
  • CCIR
  • ABSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCIR
  • ABSI Health Care
  • Exchange
  • CCIR NYSE
  • ABSI Nasdaq
  • Market Cap
  • CCIR 351.0M
  • ABSI 353.8M
  • IPO Year
  • CCIR 2024
  • ABSI 2021
  • Fundamental
  • Price
  • CCIR $11.17
  • ABSI $2.40
  • Analyst Decision
  • CCIR
  • ABSI Strong Buy
  • Analyst Count
  • CCIR 0
  • ABSI 6
  • Target Price
  • CCIR N/A
  • ABSI $7.83
  • AVG Volume (30 Days)
  • CCIR 500.9K
  • ABSI 3.6M
  • Earning Date
  • CCIR 01-01-0001
  • ABSI 03-18-2025
  • Dividend Yield
  • CCIR N/A
  • ABSI N/A
  • EPS Growth
  • CCIR N/A
  • ABSI N/A
  • EPS
  • CCIR 0.16
  • ABSI N/A
  • Revenue
  • CCIR N/A
  • ABSI $4,534,000.00
  • Revenue This Year
  • CCIR N/A
  • ABSI $257.06
  • Revenue Next Year
  • CCIR N/A
  • ABSI $112.29
  • P/E Ratio
  • CCIR $68.71
  • ABSI N/A
  • Revenue Growth
  • CCIR N/A
  • ABSI N/A
  • 52 Week Low
  • CCIR $9.92
  • ABSI $2.34
  • 52 Week High
  • CCIR $12.80
  • ABSI $6.72
  • Technical
  • Relative Strength Index (RSI)
  • CCIR N/A
  • ABSI 29.24
  • Support Level
  • CCIR N/A
  • ABSI $2.81
  • Resistance Level
  • CCIR N/A
  • ABSI $3.16
  • Average True Range (ATR)
  • CCIR 0.00
  • ABSI 0.19
  • MACD
  • CCIR 0.00
  • ABSI -0.03
  • Stochastic Oscillator
  • CCIR 0.00
  • ABSI 6.12

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: